ZA74385B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA74385B
ZA74385B ZA00740385A ZA74385A ZA74385B ZA 74385 B ZA74385 B ZA 74385B ZA 00740385 A ZA00740385 A ZA 00740385A ZA 74385 A ZA74385 A ZA 74385A ZA 74385 B ZA74385 B ZA 74385B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA00740385A
Other languages
English (en)
Inventor
R Himstedt
C Mcloughlin
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Priority to ZA00740385A priority Critical patent/ZA74385B/xx
Priority to AU77293/75A priority patent/AU485660B2/en
Priority to CH51075A priority patent/CH622947A5/de
Priority to JP50007408A priority patent/JPS5837284B2/ja
Priority to IT67104/75A priority patent/IT1036072B/it
Priority to BE152481A priority patent/BE824509A/fr
Priority to SE7500501A priority patent/SE437930B/xx
Priority to NLAANVRAGE7500552,A priority patent/NL185130C/xx
Priority to FI750113A priority patent/FI750113A/fi
Priority to GB2146/75A priority patent/GB1478742A/en
Priority to CA218,092A priority patent/CA1040532A/fr
Priority to LU71668A priority patent/LU71668A1/xx
Priority to AT31875A priority patent/AT349150B/de
Priority to DE19752501787 priority patent/DE2501787A1/de
Priority to DK012675A priority patent/DK151770C/da
Priority to ES433908A priority patent/ES433908A1/es
Priority to FR7501521A priority patent/FR2258177B1/fr
Priority to IE86/75A priority patent/IE40361B1/xx
Publication of ZA74385B publication Critical patent/ZA74385B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA00740385A 1974-01-18 1974-01-18 Pharmaceutical compositions ZA74385B (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions
AU77293/75A AU485660B2 (en) 1974-01-18 1975-01-14 Bismuth containing anti-ulcer compositions in solid form
CH51075A CH622947A5 (en) 1974-01-18 1975-01-16 Process for the production of a pharmaceutical composition which is in solid form and contains bismuth
JP50007408A JPS5837284B2 (ja) 1974-01-18 1975-01-16 セイヤクソセイブツノセイホウ
IT67104/75A IT1036072B (it) 1974-01-18 1975-01-17 Procedimento di tecnica farmaceutica per la preparazione di composizioni anti ulcera
BE152481A BE824509A (fr) 1974-01-18 1975-01-17 Procede de preparation de compositions pharmaceutiques contenant du bismuth
SE7500501A SE437930B (sv) 1974-01-18 1975-01-17 Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition
NLAANVRAGE7500552,A NL185130C (nl) 1974-01-18 1975-01-17 Werkwijze ter bereiding van vaste bismuthoudende farmaceutische preparaten, gevormde preparaten en werkwijze ter bereiding van een therapeutisch werkzame vloeistof voor orale toediening.
FI750113A FI750113A (fr) 1974-01-18 1975-01-17
GB2146/75A GB1478742A (en) 1974-01-18 1975-01-17 Pharmaceutical compositions and their preparation
CA218,092A CA1040532A (fr) 1974-01-18 1975-01-17 Procede de preparation de produits pharmaceutiques solides contenant du bismuth
LU71668A LU71668A1 (fr) 1974-01-18 1975-01-17
AT31875A AT349150B (de) 1974-01-18 1975-01-17 Verfahren zur herstellung pharmazeutischer pulver
DE19752501787 DE2501787A1 (de) 1974-01-18 1975-01-17 Verfahren zur herstellung von wismuthaltigen arzneipraeparaten
DK012675A DK151770C (da) 1974-01-18 1975-01-17 Fremgangsmaade til fremstilling af et pulverformigt vismutholdigt praeparat
ES433908A ES433908A1 (es) 1974-01-18 1975-01-17 Procedimiento para preparar composiciones farmaceuticas, solidas, conteniendo bismuto.
FR7501521A FR2258177B1 (fr) 1974-01-18 1975-01-17
IE86/75A IE40361B1 (en) 1974-01-18 1975-01-17 Pharmaceutical compositions and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA74385B true ZA74385B (en) 1975-08-27

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Country Status (18)

Country Link
JP (1) JPS5837284B2 (fr)
AT (1) AT349150B (fr)
AU (1) AU485660B2 (fr)
BE (1) BE824509A (fr)
CA (1) CA1040532A (fr)
CH (1) CH622947A5 (fr)
DE (1) DE2501787A1 (fr)
DK (1) DK151770C (fr)
ES (1) ES433908A1 (fr)
FI (1) FI750113A (fr)
FR (1) FR2258177B1 (fr)
GB (1) GB1478742A (fr)
IE (1) IE40361B1 (fr)
IT (1) IT1036072B (fr)
LU (1) LU71668A1 (fr)
NL (1) NL185130C (fr)
SE (1) SE437930B (fr)
ZA (1) ZA74385B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
EP0206626B2 (fr) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Utilisation de bismuth pour la fabrication d'un médicament destiné au traitement des désordres gastrointestinaux dûs à Campylobacter polyridis
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
EP0363502B1 (fr) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Formulation liquide contenant du bismuth, procédé pour la préparer et son utilisation
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
ES2084174T3 (es) * 1990-07-20 1996-05-01 Tillotts Pharma Ag Productos y procesos para el tratamiento del conducto alimentario.
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963781A1 (de) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Verbesserte Wismuth-Praeparate
GB1259151A (en) * 1968-12-23 1972-01-05 Willem Jacob Serfontein Bismuth complexes

Also Published As

Publication number Publication date
GB1478742A (en) 1977-07-06
AU7729375A (en) 1976-07-15
DK151770C (da) 1989-11-06
SE7500501L (fr) 1975-07-21
DK151770B (da) 1988-01-04
IT1036072B (it) 1979-10-30
IE40361B1 (en) 1979-05-09
FR2258177B1 (fr) 1978-07-21
NL185130C (nl) 1990-02-01
FR2258177A1 (fr) 1975-08-18
CA1040532A (fr) 1978-10-17
LU71668A1 (fr) 1975-06-24
DE2501787A1 (de) 1975-07-24
DE2501787C2 (fr) 1987-11-12
AU485660B2 (en) 1977-07-28
SE437930B (sv) 1985-03-25
CH622947A5 (en) 1981-05-15
JPS5837284B2 (ja) 1983-08-15
NL185130B (nl) 1989-09-01
NL7500552A (nl) 1975-07-22
IE40361L (en) 1975-07-18
JPS50116623A (fr) 1975-09-12
BE824509A (fr) 1975-07-17
ATA31875A (de) 1978-08-15
AT349150B (de) 1979-03-26
DK12675A (fr) 1975-09-15
ES433908A1 (es) 1976-11-16
FI750113A (fr) 1975-07-19

Similar Documents

Publication Publication Date Title
KE3052A (en) Pharmaceutical compositions
NZ179495A (en) 1-substituted-4-benzylpiperidines and pharmaceutical compositions
ZA74385B (en) Pharmaceutical compositions
ZA756572B (en) Shampoo compositions
ZA755998B (en) Pharmaceutical compositions
IL48508A (en) Pharmaceutical compositions comprising piperidylindole derivatives
AU487061B2 (en) Pharmaceutical compositions
PH12058A (en) Antibiotic pharmaceutical compositions
IL46965A (en) Pharmaceutical composition containing heparinoidic factor
IL47681A0 (en) Uv-photopolymerizable compositions
HK17281A (en) Pharmaceutical compositions
NZ179502A (en) Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition
ZA755802B (en) Pharmaceutical compositions
IL48098A0 (en) Pharmaceutical compositions containing diphenylethanol derivatives
PH12855A (en) Pharmaceutical compositions
HK73178A (en) Pharmaceutical compositions
ZM12375A1 (en) Compositions
ZA755515B (en) Pharmaceutical formulations
NZ178962A (en) 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions
ZA757067B (en) Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones
IE39123B1 (en) Pharmaceutical compositions
ZA742246B (en) Pharmaceutical compositions
ZA755904B (en) Pharmaceutical compositions
ZA756921B (en) Pharmaceutical compositions
ZA744340B (en) Pharmaceutical compositions